MedPass International

MedPass International, established in 1991 and based in Paris, is a prominent European Contract Research Organization (CRO) and consultancy focused on medical devices. The company specializes in medical device development, regulatory affairs, and reimbursement consultancy, catering to a diverse range of clients from start-ups to multinational corporations. MedPass has played a key role in the development of numerous innovative medical devices, including complex Class III devices and technologies in interventional cardiology and structural heart. The company provides a wide array of services, including clinical development, regulatory strategy, and market access support for medical device companies. MedPass International is well-versed in navigating the intricate European medical device regulations, helping clients bring breakthrough technologies to market. With experience serving over 1,000 medical device companies, MedPass offers tailored solutions to meet the dynamic needs of the medtech industry. In 2020, MedPass was acquired by ICON plc, enhancing its capabilities and resources in medical device and diagnostic research services.

• Employees 21
• Founded 1991
• Annual Revenue $5400000